WSH Incorporates Drug Approval Dates from BioMedTracker for Pharma Traders
The dataset will provide all relevant and potentially market-moving event dates around drug trials and approvals.
The vendor rolled out the data into Enchilada as a "soft launch" earlier this month, following a beta test period in January with a few hedge funds and other clients to whom WSH provides XML feeds.
In addition to FDA PDUFA (Prescription Drug User Fee Act) dates, BioMedTracker also provides WSH with other relevant information, such as the date when a drug enters review by the FDA, expected approval date plus any changes to that expected date, and the final notice of approval or denial for both
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
Agents are invading. Will it stick?
The Waters Wrap: Agentic features are becoming commonplace in the workflow tools of capital markets. Nyela wonders if the trend is sustainable.
TS Imagine launches new agentic platform
TSIQ can act based on client queries, using built-in agent “personas” that can be modified by users on a case-by-case basis.
BBH’s new tech affiliate, Broadridge’s tokenization platform, and more
The Waters Cooler: A recap of the major tech and data news from the past week in the capital markets.
Waters Wavelength Ep. 358: Tradeweb’s Chris Bruner
This week, Tradeweb’s chief product officer joins the podcast to discuss fixed income, prediction markets, agentic AI, and overnight trading.
Can AI beat exceptions out of the back office?
The Waters Wrap: Agentic AI can help operations teams tackle exceptions. But first, they need to get their house in order, writes Wei-Shen.
Banks brace for higher costs as chip memory runs short
A recent report from Gartner shows the price of memory is rising, putting the squeeze on firms eager to adopt AI.
Manuela Veloso on how banks can make their AI dreams reality
Former JP Morgan head of AI research says open-ended enquiry will unlock technology’s full potential.
Photonics: time for trading tech to see the light
The Waters Wrap: While the sector is dominated by Big Tech, photonic-based solutions could one day help trading firms take more control over their AI ambitions, Anthony says.
